SC

Stempoint Capital Portfolio holdings

AUM $311M
This Quarter Return
+8.92%
1 Year Return
+15.22%
3 Year Return
5 Year Return
10 Year Return
AUM
$311M
AUM Growth
+$311M
Cap. Flow
-$5.24M
Cap. Flow %
-1.69%
Top 10 Hldgs %
50.16%
Holding
74
New
18
Increased
16
Reduced
15
Closed
20
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ABUS icon
51
Arbutus Biopharma
ABUS
$732M
-467,882
Closed -$1.63M
ASND icon
52
Ascendis Pharma
ASND
$11.8B
-14,732
Closed -$2.3M
BBC icon
53
Virtus LifeSci Biotech Clinical Trials ETF
BBC
$16.2M
0
BPMC
54
DELISTED
Blueprint Medicines
BPMC
-61,927
Closed -$5.48M
CGON icon
55
CG Oncology
CGON
$2.04B
-289,823
Closed -$7.1M
CVS icon
56
CVS Health
CVS
$94B
0
CYTK icon
57
Cytokinetics
CYTK
$5.94B
-149,648
Closed -$6.01M
DYN icon
58
Dyne Therapeutics
DYN
$1.92B
-84,430
Closed -$883K
ELVN icon
59
Enliven Therapeutics
ELVN
$1.2B
-120,430
Closed -$2.37M
EWTX icon
60
Edgewise Therapeutics
EWTX
$1.57B
-180,255
Closed -$3.97M
FOLD icon
61
Amicus Therapeutics
FOLD
$2.43B
-268,919
Closed -$2.19M
IFRX icon
62
InflaRx
IFRX
$119M
-725,019
Closed -$740K
MRK icon
63
Merck
MRK
$214B
0
NBIX icon
64
Neurocrine Biosciences
NBIX
$13.8B
-21,052
Closed -$2.33M
NVO icon
65
Novo Nordisk
NVO
$251B
0
OCUL icon
66
Ocular Therapeutix
OCUL
$2.21B
-124,523
Closed -$913K
RVMD icon
67
Revolution Medicines
RVMD
$7.39B
-318,782
Closed -$11.3M
SLDB icon
68
Solid Biosciences
SLDB
$427M
-198,150
Closed -$733K
SLNO icon
69
Soleno Therapeutics
SLNO
$3.57B
-11,155
Closed -$797K
SWTX
70
DELISTED
SpringWorks Therapeutics
SWTX
-159,305
Closed -$7.03M
SYRE icon
71
Spyre Therapeutics
SYRE
$996M
-136,139
Closed -$2.2M
XENE icon
72
Xenon Pharmaceuticals
XENE
$3.03B
-274,633
Closed -$9.21M
BCAX
73
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
-47,078
Closed -$613K
SION
74
Sionna Therapeutics, Inc. Common Stock
SION
$1.09B
-60,000
Closed -$628K